181 related articles for article (PubMed ID: 12127545)
1. Binding modes of two novel dinucleotide inhibitors of HIV-1 integrase.
Guenther S; Nair V
Bioorg Med Chem Lett; 2002 Aug; 12(16):2233-6. PubMed ID: 12127545
[TBL] [Abstract][Full Text] [Related]
2. Docking dinucleotides to HIV-1 integrase carboxyl-terminal domain to find possible DNA binding sites.
Zhu HM; Chen WZ; Wang CX
Bioorg Med Chem Lett; 2005 Jan; 15(2):475-7. PubMed ID: 15603976
[TBL] [Abstract][Full Text] [Related]
3. Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain.
Molteni V; Greenwald J; Rhodes D; Hwang Y; Kwiatkowski W; Bushman FD; Siegel JS; Choe S
Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):536-44. PubMed ID: 11264582
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW
FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a nuclease-resistant, non-natural dinucleotide that inhibits HIV-1 integrase.
Taktakishvili M; Neamati N; Pommier Y; Nair V
Bioorg Med Chem Lett; 2001 Jun; 11(11):1433-5. PubMed ID: 11378371
[TBL] [Abstract][Full Text] [Related]
6. Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.
Chen X; Tsiang M; Yu F; Hung M; Jones GS; Zeynalzadegan A; Qi X; Jin H; Kim CU; Swaminathan S; Chen JM
J Mol Biol; 2008 Jul; 380(3):504-19. PubMed ID: 18565342
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of HIV-1 integrase.
Chiu TK; Davies DR
Curr Top Med Chem; 2004; 4(9):965-77. PubMed ID: 15134551
[TBL] [Abstract][Full Text] [Related]
8. Recognition and inhibition of HIV integrase by a novel dinucleotide.
Taktakishvili M; Neamati N; Pommier Y; Nair V
Bioorg Med Chem Lett; 2000 Feb; 10(3):249-51. PubMed ID: 10698446
[TBL] [Abstract][Full Text] [Related]
9. Targeting HIV-1 integrase with strand transfer inhibitors.
Li Y; Xuan S; Feng Y; Yan A
Drug Discov Today; 2015 Apr; 20(4):435-49. PubMed ID: 25486307
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of novel allosteric peptide inhibitors of HIV integrase identify new interactions at the LEDGF binding site.
Rhodes DI; Peat TS; Vandegraaff N; Jeevarajah D; Newman J; Martyn J; Coates JA; Ede NJ; Rea P; Deadman JJ
Chembiochem; 2011 Oct; 12(15):2311-5. PubMed ID: 21850718
[TBL] [Abstract][Full Text] [Related]
11. Comparative docking and CoMFA analysis of curcumine derivatives as HIV-1 integrase inhibitors.
Gupta P; Garg P; Roy N
Mol Divers; 2011 Aug; 15(3):733-50. PubMed ID: 21327540
[TBL] [Abstract][Full Text] [Related]
12. Insight into the fundamental interactions between LEDGF binding site inhibitors and integrase combining docking and molecular dynamics simulations.
De Luca L; Morreale F; Chimirri A
J Chem Inf Model; 2012 Dec; 52(12):3245-54. PubMed ID: 23194297
[TBL] [Abstract][Full Text] [Related]
13. Correlation of biological activity with active site binding modes of geminal disulfone HIV-1 integrase inhibitors.
Meadows DC; Tantillo DJ; Gervay-Hague J
ChemMedChem; 2006 Sep; 1(9):959-64. PubMed ID: 16952140
[No Abstract] [Full Text] [Related]
14. Tn5 transposase as a useful platform to simulate HIV-1 integrase inhibitor binding mode.
Barreca ML; Ortuso F; Iraci N; De Luca L; Alcaro S; Chimirri A
Biochem Biophys Res Commun; 2007 Nov; 363(3):554-60. PubMed ID: 17889829
[TBL] [Abstract][Full Text] [Related]
15. Fully flexible low-mode docking: application to induced fit in HIV integrase.
Keserû GM; Kolossváry I
J Am Chem Soc; 2001 Dec; 123(50):12708-9. PubMed ID: 11741448
[No Abstract] [Full Text] [Related]
16. Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor.
Quashie PK; Han YS; Hassounah S; Mesplède T; Wainberg MA
PLoS One; 2015; 10(6):e0128310. PubMed ID: 26046987
[TBL] [Abstract][Full Text] [Related]
17. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
[TBL] [Abstract][Full Text] [Related]
18. Rational design of novel diketoacid-containing ferrocene inhibitors of HIV-1 integrase.
da Silva CH; Del Ponte G; Neto AF; Taft CA
Bioorg Chem; 2005 Aug; 33(4):274-84. PubMed ID: 16023487
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of specific inhibitors of the 3'-processing step of HIV-1 integrase.
Chi G; Seo BI; Nair V
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):481-4. PubMed ID: 16247975
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on developing small molecule inhibitors targeting HIV-1 integrase.
Tan JJ; Liu C; Sun XH; Cong XJ; Hu LM; Wang CX; Liang XJ
Mini Rev Med Chem; 2012 Aug; 12(9):875-89. PubMed ID: 22512579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
